PMA
BSX icon

Prudent Man Advisors’s Boston Scientific BSX Stock Holding History

Prudent Man Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
18,543
+5,962
+47% +$477K 0.35% 68
2025
Q4 		$1.2M Sell
12,581
-524
-4% -$51.4K 0.44% 48
2025
Q3 		$1.28M Sell
13,105
-1,549
-11% -$160K 0.47% 48
2025
Q2 		$1.57M Buy
14,654
+3,727
+34% +$377K 0.5% 43
2025
Q1 		$1.1M Buy
10,927
+531
+5% +$53.5K 0.4% 53
2024
Q4 		$929K Sell
10,396
-567
-5% -$49.9K 0.34% 68
2024
Q3 		$919K Sell
10,963
-3,328
-23% -$262K 0.31% 78
2024
Q2 		$1.1M Buy
14,291
+541
+4% +$39.6K 0.39% 57
2024
Q1 		$942K Sell
13,750
-626
-4% -$40.3K 0.35% 66
2023
Q4 		$831K Sell
14,376
-183
-1% -$9.77K 0.31% 72
2023
Q3 		$769K Sell
14,559
-587
-4% -$30.8K 0.31% 73
2023
Q2 		$819K Sell
15,146
-239
-2% -$12.5K 0.31% 69
2023
Q1 		$770K Sell
15,385
-34
-0.2% -$1.6K 0.3% 72
2022
Q4 		$713K Buy
15,419
+4,492
+41% +$195K 0.29% 74
2022
Q3 		$423K Buy
10,927
+15
+0.1% +$602 0.2% 103
2022
Q2 		$407K Sell
10,912
-102
-0.9% -$4.15K 0.19% 106
2022
Q1 		$488K Sell
11,014
-661
-6% -$28.6K 0.2% 95
2021
Q4 		$496K Buy
11,675
+57
+0.5% +$2.4K 0.19% 101
2021
Q3 		$504K Sell
11,618
-106
-0.9% -$4.69K 0.19% 100
2021
Q2 		$501K Buy
11,724
+532
+5% +$22.4K 0.19% 97
2021
Q1 		$433K Buy
11,192
+422
+4% +$16K 0.18% 100
2020
Q4 		$387K Sell
10,770
-22
-0.2% -$793 0.16% 108
2020
Q3 		$412K Buy
10,792
+387
+4% +$14.9K 0.22% 90
2020
Q2 		$365K Buy
+10,405
New +$375K 0.32% 84

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Prudent Man Advisors's BSX Position: Q1 2026 in Review

Prudent Man Advisors increased its Boston Scientific (BSX) stake by 47% in Q1 2026, buying an estimated $477K and bringing the position to 18,543 shares worth $1.16M. The position accounts for 0.35% of the portfolio, ranked #68.

Prudent Man Advisors first reported a position in BSX in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.57M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Prudent Man Advisors held 18,543 shares of Boston Scientific worth $1.16M as of Q1 2026.
  • Prudent Man Advisors bought 5,962 Boston Scientific shares in Q1 2026, an estimated $477K.
  • Boston Scientific made up 0.35% of Prudent Man Advisors's portfolio in Q1 2026, its #68 holding.
  • Prudent Man Advisors first reported a position in Boston Scientific in Q2 2020 and has held it in 24 quarters since.
  • Prudent Man Advisors's Boston Scientific position peaked at $1.57M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Prudent Man Advisors's 13F filing for Q1 2026, filed 8 May 2026.